For example, miR-122 is highly secreted by tumor cells and promotes metastasis by adapting to the metabolic environment in the pre-metastatic niche, while down-regulation of PKM2 and glucose transporter type 1 (GLUT1) inhibits glucose metabolism in breast cancer cells [17]. Here, PKM is linked to breast carcinoma.